| 000 | 01256 a2200313 4500 | ||
|---|---|---|---|
| 005 | 20250518070853.0 | ||
| 264 | 0 | _c20201013 | |
| 008 | 202010s 0 0 eng d | ||
| 022 | _a1996-3181 | ||
| 024 | 7 |
_a10.2174/1871527318666191114092007 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aLeBlanc, Alexandre | |
| 245 | 0 | 0 |
_aStructurally Related Edaravone Analogues: Synthesis, Antiradical, Antioxidant, and Copper-Chelating Properties. _h[electronic resource] |
| 260 |
_bCNS & neurological disorders drug targets _c2019 |
||
| 300 |
_a779-790 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 |
_aAntioxidants _xchemical synthesis |
| 650 | 0 | 4 |
_aChelating Agents _xpharmacology |
| 650 | 0 | 4 | _aCopper |
| 650 | 0 | 4 |
_aEdaravone _xanalogs & derivatives |
| 650 | 0 | 4 |
_aFree Radical Scavengers _xchemical synthesis |
| 650 | 0 | 4 | _aSpectrophotometry |
| 650 | 0 | 4 | _aStructure-Activity Relationship |
| 700 | 1 | _aCuperlovic-Culf, Miroslava | |
| 700 | 1 | _aMorin, Pier Jr | |
| 700 | 1 | _aTouaibia, Mohamed | |
| 773 | 0 |
_tCNS & neurological disorders drug targets _gvol. 18 _gno. 10 _gp. 779-790 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.2174/1871527318666191114092007 _zAvailable from publisher's website |
| 999 |
_c30310349 _d30310349 |
||